fda_approval · anda · info

APOTEX — ANDA approval: POSACONAZOLE (unspecified)

Event date
2026-06-29 00:00:00Z
Observed
2026-07-09 22:53:24Z
Source ID
ANDA213331-1
Payload hash
1ad03f0d8fc66fcbe30759ce

Summary

APOTEX received ANDA approval for POSACONAZOLE (unspecified) on 2026-06-29. Dosage form: TABLET, DELAYED RELEASE. Application #: ANDA213331.

Entities

Informational only. Not legal, financial, or medical advice.